PTC Therapeutics has abandoned its latest attempt to secure FDA approval for Duchenne muscular dystrophy (DMD) treatment Translarna, after the FDA said it was unlikely to approve the drug based on the ...

In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...

PTC (NASDAQ: PTC) today reported financial results for its second fiscal quarter ended March 31, 2026. "PTC delivered solid financial results i ...

As MEDDIC Academy enters its 10th year, it highlights key milestones that helped turn MEDDIC/MEDDPICC® into a global ...

PTC Therapeutics is transitioning its growth engine from legacy drugs to new launches like Sephience, targeting rare genetic diseases with high unmet need. Pipeline catalysts, notably Votoplam for ...

With the writing apparently on the wall, PTC Therapeutics has called off its latest bid for FDA approval of its Duchenne muscular dystrophy (DMD) drug Translarna. Late Thursday, PTC revealed that it ...

DENVER (KDVR) — The Colorado Department of Revenue revealed on Wednesday how much eligible Coloradans can receive through its PTC Rebate Program and unveiled a new tax credit for Coloradans with ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Seaport-based software ...

NLC India Renewables, a wholly owned arm of NLC India Ltd, said it has entered into a joint venture agreement with PTC India to develop green energy projects. The agreement was signed on December 12, ...

NLC India Renewables Ltd, a wholly-owned subsidiary of NLC India Ltd, has signed a joint venture agreement (JVA) with PTC India Ltd to set up a green energy joint venture. The agreement was inked on ...